Irpexlacte A

Details

Top
Internal ID 424ef12d-82c5-434c-9aac-85e99e8a0d6b
Taxonomy Organoheterocyclic compounds > Tetrahydrofurans
IUPAC Name (1R,7R,8S,9R,11S)-11-hydroxy-5,5,8-trimethyl-10-oxatricyclo[7.2.1.03,7]dodec-2-ene-2-carboxylic acid
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C15H22O4/c1-7-9-5-15(2,3)6-10(9)12(13(16)17)8-4-11(7)19-14(8)18/h7-9,11,14,18H,4-6H2,1-3H3,(H,16,17)/t7-,8+,9+,11+,14-/m0/s1
InChI Key HAJPBKJDHYPJHO-RDICWGLJSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22O4
Molecular Weight 266.33 g/mol
Exact Mass 266.15180918 g/mol
Topological Polar Surface Area (TPSA) 66.80 Ų
XlogP 1.80
Atomic LogP (AlogP) 2.18
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
(1R,7R,8S,9R,11S)-11-hydroxy-5,5,8-trimethyl-10-oxatricyclo[7.2.1.03,7]dodec-2-ene-2-carboxylic acid
(1R,7R,8S,9R,11S)-11-hydroxy-5,5,8-trimethyl-10-oxatricyclo(7.2.1.03,7)dodec-2-ene-2-carboxylic acid
RefChem:148858
CHEBI:228071

2D Structure

Top
2D Structure of Irpexlacte A

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9898 98.98%
Caco-2 + 0.5113 51.13%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability + 0.5286 52.86%
Subcellular localzation Mitochondria 0.6892 68.92%
OATP2B1 inhibitior - 0.8535 85.35%
OATP1B1 inhibitior + 0.8778 87.78%
OATP1B3 inhibitior + 0.9200 92.00%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.9362 93.62%
P-glycoprotein inhibitior - 0.8746 87.46%
P-glycoprotein substrate - 0.8106 81.06%
CYP3A4 substrate + 0.5321 53.21%
CYP2C9 substrate - 0.7943 79.43%
CYP2D6 substrate - 0.8980 89.80%
CYP3A4 inhibition - 0.7935 79.35%
CYP2C9 inhibition - 0.7483 74.83%
CYP2C19 inhibition - 0.7743 77.43%
CYP2D6 inhibition - 0.9351 93.51%
CYP1A2 inhibition - 0.5518 55.18%
CYP2C8 inhibition - 0.8514 85.14%
CYP inhibitory promiscuity - 0.8989 89.89%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9300 93.00%
Carcinogenicity (trinary) Non-required 0.5537 55.37%
Eye corrosion - 0.9795 97.95%
Eye irritation - 0.8371 83.71%
Skin irritation - 0.5793 57.93%
Skin corrosion - 0.9350 93.50%
Ames mutagenesis + 0.5300 53.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6158 61.58%
Micronuclear - 0.7300 73.00%
Hepatotoxicity - 0.5444 54.44%
skin sensitisation - 0.6624 66.24%
Respiratory toxicity + 0.5667 56.67%
Reproductive toxicity + 0.7392 73.92%
Mitochondrial toxicity + 0.7500 75.00%
Nephrotoxicity + 0.4603 46.03%
Acute Oral Toxicity (c) III 0.5123 51.23%
Estrogen receptor binding - 0.5396 53.96%
Androgen receptor binding - 0.6077 60.77%
Thyroid receptor binding + 0.5521 55.21%
Glucocorticoid receptor binding - 0.5679 56.79%
Aromatase binding - 0.8788 87.88%
PPAR gamma - 0.6715 67.15%
Honey bee toxicity - 0.9052 90.52%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.6900 69.00%
Fish aquatic toxicity + 0.9872 98.72%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.21% 96.09%
CHEMBL221 P23219 Cyclooxygenase-1 93.61% 90.17%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 91.91% 91.11%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.00% 97.09%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 86.03% 96.95%
CHEMBL226 P30542 Adenosine A1 receptor 82.24% 95.93%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 81.74% 85.14%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.45% 100.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 81.20% 95.56%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 146682522
LOTUS LTS0247469
wikiData Q105024917